The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure

Thomas Tu1, Joan M Block2, Su Wang3,4

  • 1Storr Liver Centre, Westmead Clinical School and Westmead Institute for Medical Research, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW 2145, Australia.

Viruses
|May 13, 2020
PubMed

Insights

Chronic hepatitis B (CHB) causes significant psychosocial harms, including fear, stigma, and financial instability, impacting diagnosis and treatment. A cure for hepatitis B virus infection is crucial to alleviate these lifelong burdens.

Area of Science:

  • Hepatology
  • Public Health
  • Psychosocial Medicine

Background:

  • Chronic hepatitis B (CHB) is a prevalent, incurable liver disease with severe physical complications like cirrhosis and cancer.
  • Societal impacts of CHB are recognized, but often focus narrowly on mortality, morbidity, and economic factors.
  • Individuals with CHB often experience lifelong asymptomatic infection, yet face significant, underappreciated psychosocial burdens.

Purpose of the Study:

  • To review the wide-ranging psychosocial harms associated with chronic hepatitis B.
  • To emphasize how these psychosocial factors influence patient diagnosis, management, and treatment.
  • To highlight the role of the research community in mitigating these impacts and advocate for a cure.

Main Methods:

  • Literature review of psychosocial impacts of CHB.
  • Analysis of the interplay between psychosocial factors and clinical management.
  • Discussion of research community's role and potential solutions.

Main Results:

  • Psychosocial harms include fear, anxiety, financial instability, stigma, discrimination, and social rejection.
  • These impacts significantly affect patient engagement in diagnosis, management, and treatment of CHB.
  • A cure for hepatitis B virus (HBV) infection is identified as a key factor in alleviating psychosocial burdens.

Conclusions:

  • Greater recognition of the full spectrum of CHB impacts, including psychosocial aspects, is essential.
  • Addressing psychosocial harms is critical for delivering effective and meaningful results for the global CHB community.
  • Research efforts should focus on developing a cure for HBV to mitigate lifelong patient suffering.

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
606
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
219
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.0K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
120
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
155
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.7K